Immunogenicity moderation effect of interleukin-24 on myelogenous leukemia cells-Reference-Cited by-同舟云学术

Immunogenicity moderation effect of interleukin-24 on myelogenous leukemia cells

Published:2018-04 Issue:4 Volume:29 Page:353-363
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Yu Xin,Miao Jingcheng,Xia Wei,Gu Zong-Jiang

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference48 articles.

1. Acute leukemia incidence and patient survival among children and adults in the United States, 2001–2007;Dores;Blood,2012

2. Adenovirus vectors for gene therapy, vaccination and cancer gene therapy;Wold;Curr Gene Ther,2013

3. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion;Schreiber;Science,2011

4. Tumor-reactive CD8+ T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide ISA-51: association with survival;Karbach;Int J Cancer,2010

5. Tumor-reactive CD8+ T-cell clones in patients after NY-ESO-1 peptide vaccination;Karbach;Int J Cancer,2007

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overexpression of Cyclophilin A in Human Periapical Lesions;Journal of Endodontics;2019-12

2. Tumor Cells Modified with Newcastle Disease Virus Expressing IL-24 as a Cancer Vaccine;Molecular Therapy - Oncolytics;2019-09

3. Immunomodulation in leukemia: cellular aspects of anti-leukemic properties;Clinical and Translational Oncology;2019-05-24

4. MDA-7/interleukin 24 (IL-24) in tumor gene therapy: application of tumor penetrating/homing peptides for improvement of the effects;Expert Opinion on Biological Therapy;2019-01-21

5. Diallyl disulfide down-regulates calreticulin and promotes C/EBPα expression in differentiation of human leukaemia cells;Journal of Cellular and Molecular Medicine;2018-11-05